Clinical efficacy and safety analysis of 1.5% ruxolitinib cream in the treatment of facial vitiligo in adolescents: A retrospective study of 74 cases
- DOI
- 10.1016/j.jaad.2026.02.087
- Published
- 2026-06
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2026.02.087,
title = {Clinical efficacy and safety analysis of 1.5\% ruxolitinib cream in the treatment of facial vitiligo in adolescents: A retrospective study of 74 cases},
author = {Xiaojian Chen and Ruochen Zhang and He Huang and Zhengwei Zhu and Weiran Li and Min Li and Min Chen and Hequn Huang and Dawei Duan and Cong Xin and Yan Li and Bin Zhou and Yujun Sheng and Xuejun Zhang and Yan Ding and Yong Cui and Bo Zhang},
year = {2026},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2026.02.087},
url = {https://doi.org/10.1016/j.jaad.2026.02.087}
}RIS
TY - JOUR TI - Clinical efficacy and safety analysis of 1.5% ruxolitinib cream in the treatment of facial vitiligo in adolescents: A retrospective study of 74 cases AU - Xiaojian Chen AU - Ruochen Zhang AU - He Huang AU - Zhengwei Zhu AU - Weiran Li AU - Min Li AU - Min Chen AU - Hequn Huang AU - Dawei Duan AU - Cong Xin AU - Yan Li AU - Bin Zhou AU - Yujun Sheng AU - Xuejun Zhang AU - Yan Ding AU - Yong Cui AU - Bo Zhang PY - 2026 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2026.02.087 UR - https://doi.org/10.1016/j.jaad.2026.02.087 ER -
APA
Chen, X., Zhang, R., Huang, H., Zhu, Z., Li, W., Li, M., Chen, M., Huang, H., Duan, D., Xin, C., Li, Y., Zhou, B., Sheng, Y., Zhang, X., Ding, Y., Cui, Y., & Zhang, B. (2026). Clinical efficacy and safety analysis of 1.5% ruxolitinib cream in the treatment of facial vitiligo in adolescents: A retrospective study of 74 cases. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.02.087
Source records
- crossref · retrieved 2026-09-25T07:02:04.358Z